Comparison between viral vector and mRNA based COVID-19 vaccination in prevalence and severity of regional immune reactions, and 18F-FDG PET/CT features.

Narjess Ayati, Scott Evans, S Rasoul Zakavi, Simon M Gruenewald
{"title":"Comparison between viral vector and mRNA based COVID-19 vaccination in prevalence and severity of regional immune reactions, and <sup>18</sup>F-FDG PET/CT features.","authors":"Narjess Ayati,&nbsp;Scott Evans,&nbsp;S Rasoul Zakavi,&nbsp;Simon M Gruenewald","doi":"10.22038/AOJNMB.2022.63110.1443","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>The coronavirus pandemic caused by SARS-CoV-2 commenced in late 2019, and global wide vaccination appears to be the only reasonable solution to fight this dreadful virus. There are two main types of COVID-19 immunization using viral vector and mRNA-based vaccines. However, the impact of each of type on <sup>18</sup>F-FDG PET/CT needs to be accurately assessed. This study aimed to compare the <sup>18</sup>F-FDG PET/CT features of these two types of COVID-19 vaccines.</p><p><strong>Methods: </strong>A total of 188 patients referred for <sup>18</sup>F-FDG PET/CT with a recent history of either BioNTech/Pfizer or AstraZeneca COVID-19 vaccination, and a control group of 40 patients with no history of any type of recent vaccination, were included in the study. <sup>18</sup>F-FDG PET/CT studies of vaccinated patients assessed for injection site uptake and regional nodal and systemic reactions post vaccination. The data were compared to the control group and to the contralateral side for each patient. The findings were compared between patients who received Pfizer and AstraZeneca vaccines.</p><p><strong>Results: </strong><sup>18</sup>F-FDG PET/CT was semiquantitatively positive in 50.5% of the studied population for vaccine-related features. The ipsilateral axillary and infra- and supraclavicular lymph nodes were significantly larger in size and exhibited higher metabolic activity compared to the contralateral lymph nodes after both types of vaccination. The prevalence of regional nodal reactions post Pfizer and AstraZeneca vaccination was 39% and 17.9% on visual, and 61% and 47.6% on semiquantitative assessments, respectively. Patients receiving the Pfizer vaccine exhibited higher metabolic activity in the ipsilateral regional lymph nodes (p<0.05). No significant difference in the intensity of regional nodal reaction post vaccination was noted between the first four weeks.</p><p><strong>Conclusion: </strong>Significant local and regional nodal reactions are observed after both viral vector and mRNA COVID-19 vaccination with a tendency to extend toward the infra- and supraclavicular nodal stations but not to the pulmonary hilum. The greater intensity and extension of the nodal reaction after Pfizer vaccination suggests a higher possibility of false-positive results on <sup>18</sup>F-FDG PET/CT studies using mRNA vaccination technology.</p>","PeriodicalId":8503,"journal":{"name":"Asia Oceania Journal of Nuclear Medicine and Biology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803623/pdf/","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asia Oceania Journal of Nuclear Medicine and Biology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22038/AOJNMB.2022.63110.1443","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 3

Abstract

Objectives: The coronavirus pandemic caused by SARS-CoV-2 commenced in late 2019, and global wide vaccination appears to be the only reasonable solution to fight this dreadful virus. There are two main types of COVID-19 immunization using viral vector and mRNA-based vaccines. However, the impact of each of type on 18F-FDG PET/CT needs to be accurately assessed. This study aimed to compare the 18F-FDG PET/CT features of these two types of COVID-19 vaccines.

Methods: A total of 188 patients referred for 18F-FDG PET/CT with a recent history of either BioNTech/Pfizer or AstraZeneca COVID-19 vaccination, and a control group of 40 patients with no history of any type of recent vaccination, were included in the study. 18F-FDG PET/CT studies of vaccinated patients assessed for injection site uptake and regional nodal and systemic reactions post vaccination. The data were compared to the control group and to the contralateral side for each patient. The findings were compared between patients who received Pfizer and AstraZeneca vaccines.

Results: 18F-FDG PET/CT was semiquantitatively positive in 50.5% of the studied population for vaccine-related features. The ipsilateral axillary and infra- and supraclavicular lymph nodes were significantly larger in size and exhibited higher metabolic activity compared to the contralateral lymph nodes after both types of vaccination. The prevalence of regional nodal reactions post Pfizer and AstraZeneca vaccination was 39% and 17.9% on visual, and 61% and 47.6% on semiquantitative assessments, respectively. Patients receiving the Pfizer vaccine exhibited higher metabolic activity in the ipsilateral regional lymph nodes (p<0.05). No significant difference in the intensity of regional nodal reaction post vaccination was noted between the first four weeks.

Conclusion: Significant local and regional nodal reactions are observed after both viral vector and mRNA COVID-19 vaccination with a tendency to extend toward the infra- and supraclavicular nodal stations but not to the pulmonary hilum. The greater intensity and extension of the nodal reaction after Pfizer vaccination suggests a higher possibility of false-positive results on 18F-FDG PET/CT studies using mRNA vaccination technology.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
基于病毒载体和mRNA的COVID-19疫苗接种在区域免疫反应发生率和严重程度以及18F-FDG PET/CT特征方面的比较
由SARS-CoV-2引起的冠状病毒大流行于2019年底开始,全球范围内的疫苗接种似乎是对抗这种可怕病毒的唯一合理解决方案。COVID-19免疫主要有两种类型,使用病毒载体和基于mrna的疫苗。然而,每种类型对18F-FDG PET/CT的影响需要准确评估。本研究旨在比较这两种新型冠状病毒疫苗的18F-FDG PET/CT特征。方法:188例近期有BioNTech/辉瑞或阿斯利康COVID-19疫苗接种史的18F-FDG PET/CT患者,以及40例近期无任何类型疫苗接种史的对照组患者纳入研究。接种疫苗患者的18F-FDG PET/CT研究评估了注射部位的摄取以及接种后的局部淋巴结和全身反应。将每个患者的数据与对照组和对侧进行比较。研究结果在接受辉瑞和阿斯利康疫苗的患者之间进行了比较。结果:在50.5%的研究人群中,18F-FDG PET/CT在疫苗相关特征上呈半定量阳性。两种类型的疫苗接种后,同侧腋窝和锁骨下及锁骨上淋巴结的体积明显大于对侧淋巴结,并表现出更高的代谢活性。辉瑞和阿斯利康疫苗接种后的局部淋巴结反应发生率在目测中分别为39%和17.9%,在半定量评估中分别为61%和47.6%。结论:COVID-19病毒载体和mRNA疫苗接种后均可观察到明显的局部和区域淋巴结反应,且有向锁骨下和锁骨上淋巴结站延伸的趋势,但未向肺门延伸。辉瑞疫苗接种后,淋巴结反应的强度和范围更大,这表明使用mRNA疫苗接种技术进行18F-FDG PET/CT研究时假阳性结果的可能性更高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Asia Oceania Journal of Nuclear Medicine and Biology
Asia Oceania Journal of Nuclear Medicine and Biology Medicine-Radiology, Nuclear Medicine and Imaging
CiteScore
1.80
自引率
0.00%
发文量
28
审稿时长
12 weeks
期刊最新文献
18F-FDG PET/CT imaging of IgG4-producing MALT lymphoma with multiple site involvement. 99mTc-Sn-colloid SPECT/CT in thoracic splenosis after esophageal cancer surgery. A practical method for assessing quantitative scanner accuracy with long-lived radionuclides: The ARTnet insert. Assessment of awareness and knowledge regarding nuclear medicine and appropriate use of Nuclear medicine modalities, among medical students and faculty members in two academic medical institutes in North India: A Cross sectional Study. Comparison between 18F-FDG PET/CT and diffusion-weighted imaging in detection of invasive ductal breast carcinoma.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1